Meat imports to Russia from producers using ractopamine must be tested and certified free of the feed additive, the country's veterinary regulator said, denying on Saturday the requirement is a political retaliation.
The move, imposed a day after the U.S. Senate approved a bill to expand trade between Washington and Moscow that also sought to punish Russian human rights violators, could jeopardize North American meat beef and pork suppliers.
It would potentially make the United States, which exports more than $500 million a year worth of beef and pork to Russia, significantly less competitive, giving advantage to Chinese and European Union meat producers, where ractopamine is banned.
The U.S. Meat Export Federation (USMEF) said the USDA had no testing and certification program in place for ractopamine.
"The U.S. red meat industry is committed to supplying healthy, nutritious beef and pork to our customers in Russia and markets around the world," according to a USMEF statement Monday morning. "This commitment is based on the best available science and has the backing of the United States government. We are confident that a science-based solution to the disagreement over testing and certification can be found quickly so that exports of U.S. beef and pork can resume very soon."
Russia's plant and health regulator, Rosselkhoznadzor, said that as of Friday it would allow for an unidentified transition period during which in the absence of a needed certification, Russia will test each shipment itself.
"During this period the veterinary service of the suppliers have to create a system of laboratory testing of products certifying the absence of ractopamine," the regulator said in a statement posted late Friday on its website.
Rosselkhoznadzor did not specify what would happen to meat shipments already on their way, but the statement suggests the meat will be tested once it arrives in Russia.
USMEF, a non-profit trade association, said more than 210 shipping containers of U.S. pork and beef valued at about $20 million were on their way to Russia.
DENIAL OF RETALIATION
Analysts said the Russian move was linked to the U.S. Senate's passage of the "Magnitsky Act" as part of a broad trade bill, which drew an angry response from Russia where officials called it "absurd."
Some Russian news outlets incorrectly attributed the quotes on the Magnitsky legislation to USMEF, when in fact USMEF made no such comments. "I would also like to clarify that news reports stating that USMEF drew a connection between this issue and the so-called Magnitsky legislation are completely false," said a USMEF spokesman. "Those comments were made by commodities analysts who are not connected in any way with USMEF. "
Rosselkhoznadzor said on Saturday it had warned over a year ago about the "inadmissibility" of meat with ractopamine to Russia and it had sent advanced legal notices to veterinary officials in the United States, Canada, Brazil and Mexico.
"Rosselkhoznadzor was surprised to hear that some analysts linked Russia's introduction of stricter control over the presence of the beta-adrenoceptor agonist ractopamine in imported meat with the passage by the U.S. Senate on Dec. 6 of the so-called 'Magnitsky Act'," it said in a statement.
Gennady Onishchenko, Russia's chief health inspector and head of the state consumer protection agency Rospotrebnadzor, denied the requirement of testing and certifying meat imports was retaliatory.
"In Russia, (ractopamine) is not included in the register of products approved for use," Onishchenko told the news agency Interfax on Saturday.
"We can only regret that American Federation analysts on meat exports lacked even a tiny bit of imagination to classify the 27 countries of the European Union, China and all other 167 countries that have banned the use of this product as opponents of the 'Magnitsky Act' adopted by the U.S. Senate."
Ractopamine is used as a feed additive to make meat leaner, but countries such as China have banned its use despite scientific evidence that it is safe. The United Nations has agreed on acceptable levels of the drug.